Banka BioLoo Limited — Capital/Financing Update 2023

Oct 31, 2023

Registered Office : A-109 Express Apartments, Lakdi ka Pool, Hyderabad - 500004

Corporate Office : 5[th] floor, Prestige Phoenix, 1405, Uma Nagar, Begumpet, Hyderabad - 500016

==> picture [117 x 36] intentionally omitted <==

+91 8688825013 • info@bankabio.com • www.bankabio.com • CIN: L90001TG2012PLC082811

31 October 2023

To

National Stock Exchange of India Limited Exchange Plaza, Bandra Kurla Complex Bandra (East) Mumbai - 400051

Symbol: BANKA

Subject: In-principle approval for listing of 5,42,329 Equity shares of Rs. 10/- each to be allotted under “Banka BioLoo Limited Employee Stock Option Plan – 2023”.

Dear Sir/ Madam,

With reference to above captioned subject, we would like to inform you that the Company has received In-principle approval for listing of 5,42,329 Equity shares of Rs. 10/- each to be allotted under the “Banka BioLoo Limited Employee Stock Option Plan – 2023” from National Stock Exchange of India Limited (NSE) vide their letter NSE/LIST/37931 dated 30 October 2023.

The approval letter received from NSE is attached herewith.

Kindly take the same in your records.

Thank you

For Banka BioLoo Limited

ARCHANA Digitally signed by ARCHANA ARIGELA ARIGELA Date: 2023.10.31 12:57:47 +05'30'

Archana Arigela

Company Secretary & Compliance Officer Membership No. 65613

Encls as above

==> picture [451 x 76] intentionally omitted <==

Ref: NSE/LIST/37931

October 30, 2023

The Company Secretary, Banka BioLoo Limited A-109 Express Apartments, Lakdi ka Pool, Hyderabad - 500004.

Kind Attn: Ms. Archana Arigela

Dear Madam,

Sub.: In-principle approval for listing of 5,42,329 Equity shares of Rs. 10/- each allotted under Banka BioLoo Limited Employee Stock Option Plan - 2023.

We are in receipt of your letter along with statement under Regulation 10(b) as required under applicable SEBI Regulations/Circulars and subsequent correspondences thereto, seeking in-principle approval for listing of upto a maximum of 5,42,329 Equity shares of Rs. 10/- each to be allotted under Banka BioLoo Limited Employee Stock Option Plan - 2023.

In this regard, the Exchange is pleased to grant in-principle approval for the above equity shares to be allotted on exercise of options as and when exercised subject to fulfilling the following listing conditions:

1. Notification to the Exchange as per Regulation 10 (c) together with listing application only after allotment of securities and credit to the beneficiaries account or dispatch of share certificates, as may be applicable.

2. Receipt of statutory and other approvals and compliance of guidelines issued by the statutory authorities including SEBI, RBI, MCA, etc.

3. Compliance with all the guidelines, regulations, directions of the Exchange or any statutory authorities, documentary requirements from time to time.

4. Compliance of all conditions of SEBI (LODR) Regulations, 2015 as on date of listing.

5. Compliance to the Companies Act, 1956, Companies Act, 2013 and other applicable laws.

6. Submissions of documents as given in the enclosed list (as per annexure).

The Exchange reserves its right to withdraw its in-principle approval at any later stage if the information submitted to the Exchange is found to be incomplete/incorrect/ misleading/false or in contravention of any Rules, Bye-laws and Regulations of the Exchange, Listing Regulations, Guidelines/ Regulations issued by statutory authorities, etc.

Kindly note that the Exchange will issue approval for listing and trading of equity shares subject to the compliances as stated above.

Kindly note, this Exchange letter should not be construed as approval under any other Act /Regulation/rule/bye laws (except as referred above) for which the Company may be required to obtain approval from other department(s) of the Exchange. The Company is requested to separately take up matter with the concerned departments for approval, if any.

Yours faithfully,

For National Stock Exchange of India Limited

Charmi Dharod Senior Manager

Non-Confidential Non-Confidential

==> picture [294 x 71] intentionally omitted <==

==> picture [81 x 12] intentionally omitted <==

P.S. Checklist of all the further issues is available on website of the exchange at the following URL: http://www.nseindia.com/corporates/content/further_issues.htm

Annexure:

1. Certified true copy of statement under Regulation 10(c) as per the format prescribed in SEBI regulations/circulars.

2. NSDL/CDSL credit and/or dispatch of physical certificate confirmation by the R & T agent.

3. Certified true copy of Board resolution of allotment of shares.

4. List of allottees specifying the name of the allottee, number of shares allotted for the same.

5. Details of employees who have been granted options / shares in excess of 1% of share capital (in case of ESOPs) or 5% (in case of ESPS) of options / shares issued in one year.

6. Confirmation as to whether any Directors have been issued shares pursuant to ESOP/ESPS. If so, details of the issue to the Directors.

==> picture [4 x 12] intentionally omitted <==

Non-Confidential Non-Confidential